Contract development and manufacturing organization (CDMOs) for biopharma

The way forward in biologics manufacturing

The trend of outsourcing is increasing the thrust of contract development and manufacturing organizations (CDMOs) into the spotlight. There is a push towards engaging the services of CDMOs by emerging biotechnology groups which don’t have the resources to do development or manufacturing in-house; and, by larger biopharmaceutical companies which are facing capacity constraints and looking to quickly increase their current capacity. ​To meet these changing demands, it is critical for CDMOs to find ways to scale, and scale quickly, within their current footprint. At Thermo Fisher Scientific, we are able to offer a range of solutions from supporting CDMOs to serving as a CDMO.

Contact us       Download flyer

Market dynamics impacting CDMOs


Prioritizing speed


Increasing complexity


Mitigating supply challenges


Evolving role in decision making process

Scale up efficiently and effectively

Reduce complexity in your bioprocess

Mitigate supply challenges and raw material shortages

The industry is facing supply shortage, and companies must mitigate supply challenges to ensure they are able to continue their critical work. Listen to a customer’s perspective on the significance of working with a reliable partner for redundancy of supply, timing, and quality.

Reduce complexity in your bioprocess

Bioprocessing resources

Access a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing:

For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.